CD4 and myeloid sarcoma: Vitamin D treatment in multiple sclerosis (MS) patients reduced the proliferation of CD4+ T cells and myelin basic protein specific T cells, decreased the frequency of IL-6 and IL-17 secreting cells, and promoted the development of IL-10 secreting cells and CD4+CD25+ T regulatory cells [60,187].